Cristina Coman

Cristina Coman

Auto-generated profile, based on publicly available information

Cristina Coman

University of Vienna

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2021 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
LMLars Michel
Lars Michel
IHIris Helfrich
Iris Helfrich
UHUlrike Barbara Hendgen-Cotta
Ulrike Barbara Hendgen-Cotta
RMRaluca-Ileana Mincu
Raluca-Ileana Mincu
SKSebastian Korste
Sebastian Korste
Tienush RassafTienush Rassaf
Tienush Rassaf
Cardiac immune-related adverse events (irAEs) from immune checkpoint inhibition (ICI) targeting programmed death 1 (PD1) are of growing concern. Once cardiac irAEs become clinically manifest, fatality rates are high. Cardio-oncology aims to prevent detrimental effects before manifestation of severe complications by targeting early pathological changes. We therefore aimed to investigate early consequences of PD1 inhibition for cardiac integrity to prevent the development of overt cardiac disease. We investigated cardiac-specific consequences from anti-PD1 therapy in a combined biochemical and in vivo phenotyping approach. Mouse hearts showed broad expression of the ligand PDL1 on cardiac endothelial cells as a main mediator of immune-crosstalk. Using a novel melanoma mouse model, we assessed that anti-PD1 therapy promoted myocardial infiltration with CD4+ and CD8+ T cells, the latter being markedly activated. Left ventricular (LV) function was impaired during pharmacological stress, as shown by pressure–volume catheterization. This was associated with a dysregulated myocardial metabolism, including the proteome and the lipidome. Analogous to the experimental approach, in patients with metastatic melanoma (n = 7) receiving anti-PD1 therapy, LV function in response to stress was impaired under therapy. Finally, we identified that blockade of tumour necrosis factor alpha (TNFα) preserved LV function without attenuating the anti-cancer efficacy of anti-PD1 therapy. Anti-PD1 therapy induces a disruption of cardiac immune homeostasis leading to early impairment of myocardial functional integrity, with potential prognostic effects on the growing number of treated patients. Blockade of TNFα may serve as an approach to prevent the manifestation of ICI-related cardiotoxicity. Anti-PD1 immune checkpoint inhibitor therapy induces an immune-mediated disruption of cardiac integrity that can be prevented by blockade of tumour necrosis factor alpha.

1 April 2016 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
CCCristina Coman
Cristina Coman
FSFiorella Andrea Solari
Fiorella Andrea Solari
AHAndreas Hentschel
Andreas Hentschel
Albert SickmanAlbert Sickman
Albert Sickman
Rene ZahediRene Zahedi
Rene Zahedi
RARobert Ahrends
Robert Ahrends
Interconnected molecular networks are at the heart of signaling pathways that mediate adaptive plasticity of eukaryotic cells. To gain deeper insights into the underlying molecular mechanisms, a comprehensive and representative analysis demands a deep and parallel coverage of a broad spectrum of molecular species. Therefore, we introduce a simultaneous metabolite, protein, lipid extraction (SIMPLEX) procedure, a novel strategy for the quantitative investigation of lipids, metabolites, and proteins. Compared with unimolecular workflows, SIMPLEX offers a fundamental turn in study design since multiple molecular classes can be accessed in parallel from one sample with equal efficiency and reproducibility. Application of this method in mass-spectrometry-based workflows allowed the simultaneous quantification of 360 lipids, 75 metabolites, and 3327 proteins from 106 cells. The versatility of this method is shown in a model system for adipogenesis— peroxisomal proliferator-activated receptor gamma (PPARG) signaling in mesenchymal stem cells—where we utilized SIMPLEX to explore cross-talk within and between all three molecular classes and identified novel potential molecular entry points for interventions, indicating that SIMPLEX provides a superior strategy compared with conventional workflows.

2 August 2018 in Blood
Verified
Journal Article
Closed access
PDF file
BPBing Peng
Bing Peng
SGSascha Geue
Sascha Geue
CCCristina Coman
Cristina Coman
PMPatrick Münzer
Patrick Münzer
DKDominik Kopczynski
Dominik Kopczynski
RARobert Ahrends
Robert Ahrends
Platelet integrity and function critically depend on lipid composition. However, the lipid inventory in platelets was hitherto not quantified. Here, we examined the lipidome of murine platelets using lipid-category tailored protocols on a quantitative lipidomics platform. We could show that the platelet lipidome comprises almost 400 lipid species and covers a concentration range of 7 orders of magnitude. A systematic comparison of the lipidomics network in resting and activated murine platelets, validated in human platelets, revealed that <20% of the platelet lipidome is changed upon activation, involving mainly lipids containing arachidonic acid. Sphingomyelin phosphodiesterase-1 (Smpd1) deficiency resulted in a very specific modulation of the platelet lipidome with an order of magnitude upregulation of lysosphingomyelin (SPC), and subsequent modification of platelet activation and thrombus formation. In conclusion, this first comprehensive quantitative lipidomic analysis of platelets sheds light on novel mechanisms important for platelet function, and has therefore the potential to open novel diagnostic and therapeutic opportunities. Publisher9s Note: There is a Blood Commentary on this article in this issue. Key Points First quantitative analysis of dynamic platelet lipidome modulation reveals key lipids altered in platelet activation. Lipidomics in a knockout approach unravel SMPD1 as a powerful modulator of platelet lipidome and activation via regulation of SPC. Visual Abstract

24 May 2018 in Analytical Chemistry
Verified
Journal Article
Closed access
NDNiklas Danne-Rasche
Niklas Danne-Rasche
CCCristina Coman
Cristina Coman
RARobert Ahrends
Robert Ahrends

14 August 2024 in Journal of Lipid Research
Verified
Journal Article
Open access
DKDominik Kopczynski
Dominik Kopczynski
CEChrister S. Ejsing
Christer S. Ejsing
JMJeffrey G. McDonald
Jeffrey G. McDonald
TBTakeshi Bamba
Takeshi Bamba
EBErin S. Baker
Erin S. Baker
GLGerhard Liebisch
Gerhard Liebisch
The rapid increase in lipidomic studies has led to a collaborative effort within the community to establish standards and criteria for producing, documenting, and disseminating data. Creating a dynamic easy-to-use checklist that condenses key information about lipidomic experiments into common terminology will enhance the field's consistency, comparability, and repeatability. Here, we describe the structure and rationale of the established Lipidomics Minimal Reporting Checklist to increase transparency in lipidomics research.

25 April 2017 in The Analyst
Verified
Journal Article
Open access
PDF file
Evelyn RamplerEvelyn Rampler
Evelyn Rampler
CCCristina Coman
Cristina Coman
GHGerrit Hermann
Gerrit Hermann
Albert SickmanAlbert Sickman
Albert Sickman
RARobert Ahrends
Robert Ahrends
GKGunda Koellensperger
Gunda Koellensperger
Quantification is an essential task in comprehensive lipidomics studies challenged by the high number of lipids, their chemical diversity and their dynamic range of the lipidome. In this work, we introduce lipidome isotope labeling of yeast (LILY) in order to produce (non-radioactive) isotopically labeled eukaryotic lipid standards in yeast for normalization and quantification in mass spectrometric assays. More specifically, LILY is a fast and efficient in vivo labeling strategy in Pichia pastoris for the production of 13C labeled lipid library further paving the way to comprehensive compound-specific internal standardization in quantitative mass spectrometry based assays. More than 200 lipid species (from PA, PC, PE, PG, PI, PS, LysoGP, CL, DAG, TAG, DMPE, Cer, HexCer, IPC, MIPC) were obtained from yeast extracts with an excellent 13C enrichment >99.5%, as determined by complementary high resolution mass spectrometry based shotgun and high resolution LC-MS/MS analysis. In a first proof of principle study we tested the relative and absolute quantification capabilities of the 13C enriched lipids obtained by LILY using a parallel reaction monitoring based LC-MS approach. In relative quantification it could be shown that compound specific internal standardization was essential for the accuracy extending the linear dynamic range to four orders of magnitude. Excellent analytical figures of merit were observed for absolute quantification for a selected panel of 5 investigated glycerophospholipids (e.g. LOQs around 5 fmol absolute; typical concentrations ranging between 1 to 10 nmol per 108 yeast cell starting material; RSDs <10% (N = 4)).